Mon - Fri 8:00 - 6:30

Because everything we do in life affects our health and legacy.

Health & Wellness

Health & Wellness

Chromosomal abnormality scores unlock path to personalized immunotherapy

On HALO

1 hour ago

In a newly published article in Nature Genetics, researchers from the University of Chicago have identified tumor aneuploidy—an imbalance in the number of chromosomes—as a powerful biomarker associated with resistance to immunotherapy across cancer types. The study emphasizes how combining immunotherapy with radiation may help overcome the issue of therapy resistance, offering a new framework for predicting treatment response and personalizing cancer therapy.

Credit Goes To: Source

1 hour ago
On HALO

Opinion and Comments